Skip to main content
Signal8

Ferguson James J. III

SEC insider (Form 3/4/5 filer). CIK 0001769041. Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in RADNOR, PA.

Companies Ferguson James J. III has filed insider reports for

  • Mineralys Therapeutics, Inc. (MLYS): Officer, Chief Medical Officer
  • Cadrenal Therapeutics, Inc. (CVKD): Officer, Chief Medical Officer
Ferguson James J. III profile photo

Ferguson James J. III

CIK: 0001769041

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Mineralys Therapeutics, Inc. logo
MLYS

Mineralys Therapeutics, Inc.

Officer
Cadrenal Therapeutics, Inc. logo
CVKD

Cadrenal Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Aug 10, 2026
    Award
    Direct
    102.4K shares-
  • Cadrenal Therapeutics, Inc. logo
    CVKD

    Cadrenal Therapeutics, Inc.

    Feb 5, 2025
    Award

    Stock Options

    Direct
    60K shares-

1-2 of 2